Biopharmaceutical processes: A glance into the 21st century

BioProcess International

Volumn 7, Issue SUPPL.1, 2009, Pages 4-11

  Anicetti, Vince ^a  

^a Biochemical Quality for Genentech ^*

Author keywords

[No Author keywords available]

Indexed keywords

AFFINITY CHROMATOGRAPHY; BIOMEDICINE; BIOPROCESS; BIOTECHNOLOGY; DRUG INDUSTRY; LARGE SCALE PRODUCTION; REVIEW;

EID: 77953411034     PISSN: 15426319     EISSN: None     Source Type: Trade Journal    
DOI: None     Document Type: Review

References (6)

1. Fontes N and van Reis R. Advances in Technology and process Development for Industrial Scale Monoclonal Antibody Purification (in press).
2. Gottschalk U. "Bioseparation in Antibody Manufacturing: The Good, The Bad and The Ugly," American Chemical Society and American Institute of Chemical Engineers (Washington, DC, USA, 2008).
3. Follman DK, Fahrner RL. Factorial Screening of Antibody Purification Processes Using Three Chromatography Steps without Protein A. J. Chromatogr. A 1024 2008: 70-85.
4. Low D, O'Leary R, Pujar NS. Future of Antibody Purification. J. Chromatogr. B 848 2007: 48-63.
5. Metha A, et al. Non-Affinity Purification of Therapeutic Monoclonal Antibodies (submitted for publication).
6. Odum J. "Trends in Biopharmaceutical Manufacturing Facility Design: What's Hot!" Pharmaceutical Engineering (ISPE, Tampa, Florida, USA, 2005).